The Worldwide Prostate Cancer Minimally Invasive Surgery Industry is Expected to Reach $30 Billion by 2027: Increasing Demand for Minimally Invasive Surgery Drives Growth

Global Prostate Cancer Minimally Invasive Surgery Market

Dublin, Dec. 23, 2022 (GLOBE NEWSWIRE) -- The "Global Prostate Cancer Minimally Invasive Surgery Market (2022-2027) by Product Type, Application, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.The Global Prostate Cancer Minimally Invasive Surgery Market is estimated to be USD 19.25 Bn in 2022 and is expected to reach USD 30.03 Bn by 2027, growing at a CAGR of 9.3%.

Report Attribute

Details

No. of Pages

189

Forecast Period

2022 - 2027

Estimated Market Value (USD) in 2022

$19.25 Billion

Forecasted Market Value (USD) by 2027

$30.03 Billion

Compound Annual Growth Rate

9.3%

Regions Covered

Global

Market dynamics are forces that impact the prices and behaviors of the Global Prostate Cancer Minimally Invasive Surgery Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing risks.

Company ProfilesThe report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Accuray Inc., Bard Cancer Diagnostics, Becton, Dickinson and Company, Boston Scientific Corp., Eckert & Ziegler Ag, Profound Medical Corp., SonaCare Medical LLC, etc.Countries Studied

America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)

Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)

Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)

Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive QuadrantThe report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.Ansoff AnalysisThe report presents a detailed Ansoff matrix analysis for the Global Prostate Cancer Minimally Invasive Surgery Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.The analyst analyses the Global Prostate Cancer Minimally Invasive Surgery Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.Why buy this report?

The report offers a comprehensive evaluation of the Global Prostate Cancer Minimally Invasive Surgery Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.

The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.

The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.

The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

A complete analysis of the market, including the parent industry

Important market dynamics and trends

Market segmentation

Historical, current, and projected size of the market based on value and volume

Market shares and strategies of key players

Recommendations to companies for strengthening their foothold in the market

Key Topics Covered: 1 Report Description2 Research Methodology3 Executive Summary4 Market Dynamics4.1 Drivers4.1.1 Rising Prevalence of Prostate Cancer Along with Rapidly Aging Population 4.1.2 Increasing Demand for Minimally Invasive Surgery4.2 Restraints4.2.1 Surgery Complications4.3 Opportunities4.3.1 Development of New Minimally Invasive Instruments4.4 Challenges4.4.1 Dearth of Skilled Personnel5 Market Analysis5.1 Regulatory Scenario5.2 Porter's Five Forces Analysis5.3 Impact of COVID-195.4 Ansoff Matrix Analysis 5.5 PESTLE Analysis 6 Global Prostate Cancer Minimally Invasive Surgery Market, By Product Type6.1 Introduction6.2 Hand6.3 Monitoring & Visualization6.4 Powered7 Global Prostate Cancer Minimally Invasive Surgery Market, By Application7.1 Introduction7.2 Laparoscopy7.3 Brachytherapy7.4 Cryosurgery8 Americas' Prostate Cancer Minimally Invasive Surgery Market8.1 Introduction8.2 Argentina8.3 Brazil8.4 Canada8.5 Chile8.6 Colombia8.7 Mexico8.8 Peru8.9 United States8.10 Rest of Americas9 Europe's Prostate Cancer Minimally Invasive Surgery Market9.1 Introduction9.2 Austria9.3 Belgium9.4 Denmark9.5 Finland9.6 France9.7 Germany9.8 Italy9.9 Netherlands9.10 Norway9.11 Poland9.12 Russia9.13 Spain9.14 Sweden9.15 Switzerland9.16 United Kingdom9.17 Rest of Europe10 Middle East and Africa's Prostate Cancer Minimally Invasive Surgery Market10.1 Introduction10.2 Egypt10.3 Israel10.4 Qatar10.5 Saudi Arabia10.6 South Africa10.7 United Arab Emirates10.8 Rest of MEA11 APAC's Prostate Cancer Minimally Invasive Surgery Market11.1 Introduction11.2 Australia11.3 Bangladesh11.4 China11.5 India11.6 Indonesia11.7 Japan11.8 Malaysia11.9 Philippines11.10 Singapore11.11 South Korea11.12 Sri Lanka11.13 Thailand11.14 Taiwan11.15 Rest of Asia-Pacific 12 Competitive Landscape12.1 IGR Competitive Quadrant12.2 Market Share Analysis12.3 Strategic Initiatives12.3.1 M&A and Investments12.3.2 Partnerships and Collaborations12.3.3 Product Developments and Improvements13 Company Profiles 13.1 Accuray Inc.13.2 Bard Cancer Diagnostics13.3 Becton, Dickinson and Company13.4 Boston Scientific Corp.13.5 Eckert & Ziegler Ag13.6 EDAP TMS SA13.7 Elekta AB13.8 HealthTronics Inc.13.9 Intuitive Surgical13.10 Isoray Inc.13.11 Profound Medical Corp.13.12 Provision Healthcare13.13 Siemens Healthineers Ag13.14 SonaCare Medical LLC13.15 Theragenics Corp.13.16 Varian Medical Systems, Inc.14 Appendix

For more information about this report visit URL

Attachment

Global Prostate Cancer Minimally Invasive Surgery Market